NIR In-Depth Focus 2017
Posted: 22 February 2017 | European Pharmaceutical Review | 1 comment
In this NIR In-Depth Focus: Monitoring and controlling drug products and manufacturing processes with NIRS; Development of a NIRS method for quantification of a minor polymorphic form; and an Expert View with Metrohm Process Analytics…
- Monitoring and controlling drug products and manufacturing processes with NIRS
David P. Elder, David P. Elder Consultancy - Development of a NIRS method for quantification of a minor polymorphic form
Stephanie Brookes, AstraZeneca - Expert View
With Metrohm Process Analytics
This NIR In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
OK